Introduction
Acute mesenteric venous thrombosis (MVT) is an uncommon but established cause of intestinal ischaemia, distinct from mesenteric arterial occlusion. Diagnosis of early MVT is difficult due to lack of characteristic laboratory abnormalities or distinct physical features prior to the development of gut ischemia or autopsy. 1 Early identification of the condition allows for conservative treatment with anticoagulation and improved outcomes. 2 This has led to a change in the approach to the initial management with nonoperative therapy being preferred to surgery. However, bowel stricture may develop in rare cases due to ischaemia, and a close follow-up of every patient after treatment for mesenteric vein thrombosis is necessary to ensure early diagnosis of this compli-cation. We report a case of extensive thrombosis of the proximal portal vein and entire superior mesenteric vein successfully treated conservatively, but whom seven months later developed small bowel obstruction due to stricture.
Case report
AD, a 64-year-old man was an emergency admission with vague abdominal discomfort of two weeks duration, acute upper abdominal pain, loose stools, fresh rectal bleeding and vomiting. His past medical history included pulmonary embolism 14 months previously for which he had been under anticoagulation therapy with warfarin for six months and hypertension treated with lisinopril and amlodipine. He previously smoked a pipe (one ounce per day) for 12 years and stopped eight years prior to admission. He had no history of obesity.
On admission he exhibited tenderness in the mid-abdominal and right upper quadrant regions. Routine laboratory evaluation revealed leucocytosis [count of 12.7 × 10 9 /L, with predominant neutrophilia (neutrophils 11.4)], a raised C-reactive protein (CRP) of 111 (normal: 0.1-5 mg/L) and normal liver function tests. On suspicion of biliary pathology, an abdominal Ultrasound was performed, which revealed significant free fluid within the abdomen and a long segment of thickened small bowel thought to be due to inflammatory bowel disease. A contrast enhanced abdominal computed tomography (CT) showed extensive thrombosis of the proximal portal vein and the entire length of the superior mesenteric vein (SMV) with small bowel ischaemia extending from the terminal ileum to the mid jejunal loops (Fig. 1 ). An incidental finding of a 6 mm well defined, peripherally based nodule in the right lower pulmonary lobe was noted but this was discounted when a follow-up thorax CT performed three months later without any progression.
AD was started on anticoagulation with high dose of enoxaparin (low molecular weight heparin) 150 mg daily in addition to IV antibiotics (co-trimoxazole and metronidazole). Furthermore, he was commenced on IV fluids; a nasogastric tube was inserted to relieve bowel obstruction, and parenteral nutrition via a central venous catheter. AD responded to these conservative measures and resumed normal bowel movement. The fluorescently labelled inactive toxin aerolysin (FLAER) test for paroxysmal nocturnal haemoglobinuria (PNH) and DNA PCR V617F detection of Janus Kinase 2 (JAK2) mutation yielded negative results. Anticoagulation was changed to warfarin, aiming on an INR of 2.5, and he was discharged home 12 days after admission. AD was seen in the outpatient clinic at three and six months and finally discharged for care.
AD was readmitted as an emergency with a one day cramping abdominal pain, distention and biliary vomiting seven months after his initial presentation. Examination revealed abdominal distention with palpable bowel loops, diffuse abdominal tenderness and normal digital rectal examination. Routine laboratory evaluation revealed leucocytosis (11.8 × 10 9 /L) and a CRP of 10 mg/L. CT imaging of the abdomen revealed features of mechanical small bowel obstruction (Fig. 2) , most probably due to a post ischaemic small bowel stricture. The previously noted thrombus in the SMV had resolved. The symptoms resolved with conservative treatment, but he was electively re-admitted one week later for segmental resection of 30 cm of small bowel with end-to-end anastomosis. He did well and was discharged home five days later. Histological evaluation of the specimen revealed ulceration and active chronic inflammation with perforation (histopathological finding only) and surrounding granulation tissue formation without any evidence of neoplasia.
Discussion
MVT is a rare condition accounting for between 1 in 15,000 and 1 in 5000 admissions to hospital and 6-9% of all cases of acute mesenteric ischemia. 3, 4 The prevalence of MVT has increased over the past two decades with the increased use of contrast-enhanced CT in patients presenting with abdominal pain and those with portal hypertension. CT is generally the imaging modality of choice due to its high sensitivity (90-100%), wide availability and relatively low cost. Ultrasound with Doppler analysis of flow in the mesenteric and portal venous systems has also been used with success, albeit with a lower sensitivity (73-80%) and higher level of technical difficulty. 1 Different pathophysiologic mechanisms have been postulated for acute thrombus formation, local factors, such as recent splenectomy or pancreatitis associated with initial thrombosis in the large veins; and systemic hypercoagulable factors such as protein C deficiency or myeloproliferative disease that lead to thrombosis beginning in the intramural venules, vasa recta and venous arcades. 5 The main causes of MVT are abdominal malignant neoplasm, surgery, inflammatory conditions, inherited disorders (protein C or S deficiency, factor V Leiden deficiency, antithrombin deficiency), or acquired (hematologic diseases: polycythaemia vera, myelofibrosis, thrombocythaemia, JAK2 gene sequence variation, antiphosholipid antibodies, paroxysmal nocturnal haemoglobinuria; non hematologic diseases: malignancy, oral contraceptive pills, pregnancy, nephrotic syndrome, hyperhomocysteinaemia). [6] [7] [8] Detection of the JAK2 sequence variation has replaced bone marrow examination as the first test for screening myeloproliferative diseases because it can differentiate reactive thrombocytosis from essential thrombocythaemia and primary from secondary polycythaemia. 9 With the use of more extensive investigation, the frequency of patients with primary MVT has decreased, varying from 0% to 49% in the literature. 10 Investigations did not yield any underlying aetiology in our case and it can therefore be assumed he had idiopathic or primary MVT.
MVT impairs venous return from the bowel, resulting in venous engorgement and ischemia. With rapid and complete occlusion of mesenteric veins, there may be insufficient time for development of a collateral circulation leading to transmural bowel infarction. The transition from normal to ischemic bowel is gradual, unlike in arterial ischemia when it is more abrupt. Arterial spasm secondary to venous engorgement may occur, with resulting irreversible bowel ischemia, despite treatment of venous thrombosis. Associated portal venous thrombosis as in this case can be seen if the disease originates in the major veins instead of the small vena rectae. Thrombosis limited to mesenteric veins results in earlier and more frequent development of infarction compared to portal combined with mesenteric venous thrombosis. This is thought to be due to the fact that with MVT, usually the thrombotic process starts in the small veins within the bowel wall thereby not allowing time for gut drainage via the collateral system. 11 With transmural infarction, there is loss of integrity of the bowel mucosa, allowing bacterial translocation and potential for occurrence of lactic acidosis, sepsis, multiorgan failure and death. 6 The management of MVT includes preventing further extension of the thrombus and intestinal infraction in the short term; and avoiding the sequela of mild gut ischaemia and recurrence of thrombosis. Anticoagulation is the main stay of management. [2] [3] [4] It is not only beneficial in recanalising thrombosed veins 12 , but reduces the mean duration of hospital stay, hospital mortality, need for surgery and the risk of short bowel syndrome. 2 This should be combined with other ancillary measures, such as pain control, replacement of fluids, including blood transfusion when needed for gastrointestinal bleeding, nasogastric aspiration, broad-spectrum antibiotics. 13 Prophylactic antibiotics are usually required to deal with potential sepsis due to bacterial translocation through the oedematous bowel wall as a result of venous congestion. Bowel rest and total parenteral nutrition support is beneficial as absorption from the intestine is initially impaired.
When intestinal infarction is suspected, immediate exploration of the abdomen is advised. Bowel viability at surgery is determined by visual inspection, Doppler ultrasonography, or fluorescein infusion, with the latter being the most accurate mean for detecting bowel viability. 13, 14 Resection and anastomosis is the standard procedure, with the goal of conserving as much bowel as possible. 1 A planned "second-look" operation during the first 24-48 postoperative hours, to reassess any intestinal segments of questionable viability may limit the extent of the initial resection. 3 For obvious reasons, resection for a late occurring stricture has better prognosis than for early spreading bowel infarction. 10 Direct and indirect portal vein and superior mesenteric vein thrombolysis have been used in patients with high risk for bowel obstruction, but without obvious intestinal necrosis, perforation and peritonitis. 15 Jun K.W. et al. reported two patients with portal and superior mesenteric vein thrombosis who were successfully treated by percutaneous transhepatic mechanical thrombectomy-assisted thrombolysis. They however, noted that because MVT is a rare disease, there was insufficient evidence regarding the efficacy of mechanical thrombectomy. 16 Stenosis of the small bowel is rarely mentioned in reports of MVT suggesting it may be a rare complication. 17, 18 The mechanism is probably due to mild to moderate ischaemia not severe enough to cause immediate infarction. In our patient, the bowel occlusion developed during the post-thrombotic course, and resulted in surgical resection. As the patient improved promptly with conservative management, it was adjudged better to perform his operation electively on the next available list. The diagnosis of intestinal stricture in patients with a history of MVT should probably be considered more often and earlier in the presence of abdominal symptoms. This would lead to more prompt treatment and better outcome.
Conclusion
This case demonstrates that MVT can be reversed by effective anticoagulation. However, the price paid for a mild to moderate effect on the bowel may be significant stricture later on. Patients escaping early bowel resection due to massive MVT leading to bowel infarction may still require resection later due to stricture. Patients need to be counselled along these lines.
